查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1978934

PET-CT扫描仪市场：按设备类型、服务类型、机架类型、应用和最终用户划分－2026-2032年全球市场预测

PET-CT Scanners Market by Device Type, Service Type, Gantry Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，PET-CT 扫描仪市场价值将达到 29.7 亿美元，到 2026 年将成长到 31.3 亿美元，到 2032 年将达到 45.7 亿美元，复合年增长率为 6.33%。

主要市场统计数据
基准年 2025 29.7亿美元
预计年份：2026年 31.3亿美元
预测年份 2032 45.7亿美元
复合年增长率 (%) 6.33%

PET-CT影像的策略性展望：概述其临床意义、技术进步以及对医疗保健系统采购和服务提供的影响。

正子断层扫描（PET-CT）已发展成为一项突破性的影像技术，它融合了功能性和解剖性诊断。 PET-CT能够同时可视化代谢活动和形态细节，为肿瘤学、循环系统和神经病学等关键临床路径提供支持，并促进研究和治疗诊断学（治疗与诊断的整合）。除了临床价值外，PET-CT系统还在重塑医院、诊断中心和研究机构的工作流程、资本投资计画和服务模式。

检测器创新、人工智慧软体、不断发展的示踪生态系统和新的部署模式如何共同重塑临床工作流程、采购和服务策略。

在PET-CT系统领域，多项整合变革正在发生，这些变革正在重塑临床工作流程、供应链和商业化策略。检测器灵敏度和重建技术的快速提升，使得扫描时间得以缩短，病灶检出更加精准，从而显着提高了工作流程效率和诊断可靠性。同时，软体主导的进步，尤其是在人工智慧（AI）和定量成像领域的发展，正在提升整合平台的价值，这些平台能够提供决策支援、自动化品管和简化的报告流程。

本研究评估了近期关税调整对医疗影像硬体和关键零件的采购经济性、供应链韧性和筹资策略的影响。

主要经济体关税调整的累积效应正在产生一系列营运和策略影响，相关人员应认真考虑。提高医疗影像设备及组件的进口关税通常会导致最终用户总体成本上升，迫使采购团队重新评估总拥有成本 (TCO) 并探索替代筹资策略。由于关税使某些供应路线在经济上不利，製造商和供应商可能会加快生产本地化、实现采购地点多元化或重组组件采购系统，以减轻贸易壁垒的影响。

将临床应用、设备类型、最终用户需求、服务模式和机架架构与策略决策连结起来的基于细分的洞察。

精准理解产品和服务细分对于将技术交付与临床应用案例和医疗机构能力相匹配至关重要。从临床应用角度来看，循环系统、神经和肿瘤领域是明显的市场需求驱动因素。尤其肿瘤领域，其发展日新月异，基于FDG（氟代脱氧葡萄糖）的影像技术支援广泛的代谢评估，而非FDG示踪剂则针对特定的生物路径或受体谱，二者之间存在差异。这些应用层面的差异会影响扫描器的选择标准、示踪剂的物流以及影像通讯协定的设计。

美洲、欧洲、中东、非洲和亚太地区的区域特征会影响不同医疗保健系统的采购选择、服务模式和追踪物流。

区域趋势造就了不同的需求特征和营运考量，影响相关人员对投资和部署的优先顺序。在美洲，医疗保健系统采用多种支付模式和资本化方法，大规模三级医疗机构往往是先进影像技术的早期采用者。因此，整合的工作流程、强大的服务网络以及与放射性示踪剂的广泛兼容性对于支持复杂的肿瘤学、神经病学和心臟影像项目至关重要。

竞争优势正在向一个整合平台转移，该平台结合了硬体效能、软体智慧、卓越的服务和策略追踪器伙伴关係。

竞争格局日益受到硬体创新、软体生态系统和服务卓越性三者交互作用的影响。领先的供应商正在寻求将可扩展的软体解决方案和平台功能结合的策略，以实现定量成像、工作流程自动化和远距离诊断。与放射性药物供应商和研究机构的伙伴关係正成为差异化价值提案的核心，从而能够提供客製化的示踪剂支持方案，并产生临床证据，进而巩固其在诊断领域的地位。

为製造商、供应商和经销商提供切实可行的优先建议，以增强供应韧性、扩大服务价值并加速 PET-CT 技术的临床部署。

为了兼顾临床影响和商业性价值，产业领导者应采取务实且优先的行动方案，在短期应对能力和长期策略定位之间取得平衡。首先，应实现价值链多元化，并评估区域组装和本地伙伴关係的机会，以降低贸易政策波动带来的风险，并缩短关键备件的前置作业时间。这种务实的做法将增强服务的连续性，并在不同的支付方环境下提供采购柔软性。

采用透明的混合方法研究途径，结合一手访谈、技术审查、监管分析和交叉检验，确保获得稳健且可操作的见解。

本报告的研究整合基于混合方法，交叉检验了来自一手研究、技术文献和监管文件的发现。一手研究包括对临床负责人、影像物理学家、服务经理和采购专家的结构化访谈，揭示了不同医疗机构在营运方面面临的挑战、技术重点和决策标准。此外，也参考了设备层面的技术评测、同侪审查文章和已发布的监管文件，以检验性能特征和合规途径。

结论是：将技术进步、服务模式和政策趋势与策略挑战联繫起来，以优化 PET-CT 的采用、临床价值和韧性。

本执行摘要中的综合分析表明，PET-CT 仍然是一项至关重要的诊断和研究工具，其策略价值因近期技术和组织变革而得到提升。检测器技术、重建演算法以及软体主导的工作流程改进方面的创新正在提高诊断率和营运效率，而示踪剂的发展趋势和混合临床模式正在拓展该技术的临床应用范围。同时，贸易政策的变化以及采购、监管和基础设施的区域差异，正在为不同地区带来独特的营运挑战和策略机会。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 PET-CT扫描仪市场：依设备类型划分

  • 固定的
  • 移动的

第九章 PET-CT扫描仪市场：依服务类型划分

  • 安装
  • 维护
  • 升级

第十章：PET-CT扫描仪市场（依机架类型划分）

  • 多切面
  • 单切片

第十一章 PET-CT扫描仪市场：按应用领域划分

  • 循环系统
  • 神经病学
  • 肿瘤学
    • FDG示踪剂
    • 非FDG示踪剂

第十二章 PET-CT扫描仪市场：依最终用户划分

  • 诊断中心
  • 医院
    • 私立医院
    • 公立医院
  • 研究机构

第十三章 PET-CT扫描仪市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 PET-CT扫描仪市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 PET-CT扫描仪市场：按国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国PET-CT扫描仪市场

第十七章：中国PET-CT扫描仪市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Analogic Corporation
  • Canon Medical Systems Corporation
  • Fujifilm Holdings Corporation
  • General Electric Company
  • Hitachi, Ltd.
  • Koninklijke Philips NV
  • MR Solutions Ltd.
  • Neusoft Medical Systems Co., Ltd.
  • PerkinElmer, Inc.
  • Positron Corporation
  • Segami Corporation
  • Shimadzu Corporation
  • Siemens Healthineers AG
  • United Imaging Healthcare Co., Ltd.
Product Code: MRR-521BAA36EA75

The PET-CT Scanners Market was valued at USD 2.97 billion in 2025 and is projected to grow to USD 3.13 billion in 2026, with a CAGR of 6.33%, reaching USD 4.57 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.97 billion
Estimated Year [2026] USD 3.13 billion
Forecast Year [2032] USD 4.57 billion
CAGR (%) 6.33%

A strategic orientation to PET-CT imaging that frames its clinical relevance, technological evolution, and implications for procurement and service delivery within healthcare systems

Positron emission tomography-computed tomography (PET-CT) has evolved into a cornerstone imaging modality, uniquely positioned at the intersection of functional and anatomical diagnostics. Its capacity to visualize metabolic activity alongside morphological detail underpins crucial clinical pathways across oncology, cardiology, and neurology, while supporting research and theranostic applications. Beyond clinical value, PET-CT systems shape workflows, capital planning, and service models for hospitals, diagnostic centers, and research institutions.

Technological progress in detector materials, image reconstruction algorithms, and integrated software platforms has enhanced image fidelity, scan speed, and quantitative accuracy. These advances, together with growing interest in novel radiotracers and hybrid diagnostic-therapeutic protocols, have redefined expectations for diagnostic yield and patient throughput. As a result, stakeholders must navigate a more complex procurement landscape where device capabilities, tracer ecosystems, and service commitments converge to influence clinical and economic outcomes.

In this context, strategic decision-making requires a holistic view that encompasses device architecture, gantry performance, service and upgrade pathways, and end-user operational needs. The subsequent sections synthesize transformative shifts affecting technology adoption, trade-policy headwinds, segmentation nuances, regional dynamics, competitive imperatives, and actionable steps for leaders. The aim is to provide a structured narrative that supports informed choices across clinical, financial, and regulatory domains.

How detector innovation, AI-enabled software, evolving tracer ecosystems, and new deployment models are jointly reshaping clinical workflows, procurement, and service strategies

The landscape for PET-CT systems is undergoing several convergent shifts that are transforming clinical workflows, supply chains, and commercialization strategies. Rapid improvements in detector sensitivity and reconstruction techniques are enabling shorter scan times and finer lesion detectability, yielding tangible workflow efficiencies and diagnostic confidence. Concurrently, software-driven advancements-particularly in artificial intelligence and quantitative imaging-are increasing the value of integrated platforms that offer decision support, automated quality control, and streamlined reporting.

On the operational front, healthcare providers are evaluating new deployment models that balance fixed installations with mobile or decentralized services to reach underserved populations and optimize scanner utilization. This transition is reinforced by a growing emphasis on service contracts, remote diagnostics, and preventive maintenance programs that preserve uptime and extend asset life. At the same time, the tracer ecosystem is diversifying: while established radiotracers remain central, research into non-FDG agents and theranostic pairs is accelerating, prompting closer collaboration between device manufacturers, radiopharmaceutical suppliers, and clinical teams.

Finally, regulatory expectations and reimbursement frameworks are evolving to address quality assurance, data governance, and value-based care. These changes are encouraging vendors and providers to prioritize interoperable systems, robust documentation, and outcomes-oriented evidence generation. Taken together, these transformative shifts are elevating the role of integrated technology-service partnerships and strategic planning in shaping how PET-CT capabilities are acquired, deployed, and sustained.

Assessing how recent tariff adjustments have altered sourcing economics, supply chain resilience, and procurement strategies for imaging hardware and critical components

The cumulative impact of tariff changes imposed by a major economy has created a set of operational and strategic effects that stakeholders must weigh carefully. Increased import duties on imaging hardware and components typically result in higher landed costs for end users, prompting procurement teams to reassess total cost of ownership considerations and to explore alternative sourcing strategies. As tariffs render some supply routes less economical, manufacturers and suppliers may accelerate localization of manufacturing, diversify sourcing footprints, or reconfigure component sourcing to mitigate exposure to trade barriers.

Beyond immediate cost implications, tariff-driven shifts can introduce friction into existing supply chains, generating longer lead times for critical spare parts and replacement modules. This risk underscores the importance of service resilience and inventory planning for providers that rely on rapid access to components to maintain clinical continuity. Moreover, regulatory compliance and customs procedures can add administrative burden to cross-border transactions, influencing contract terms, warranty structures, and the negotiation of service-level agreements.

In response, stakeholders tend to recalibrate procurement strategies, increase emphasis on modular designs that facilitate local assembly or repair, and strengthen partnerships with regional distributors and service providers. Concurrently, there is a tendency to prioritize devices with lower import intensity or to leverage financing mechanisms that smooth capital expenditure impacts. Taken together, these adaptations demonstrate how trade policy shocks propagate across the ecosystem, affecting capital decisions, service reliability, and the pace at which new technologies are adopted.

Segmentation-driven insights that connect clinical applications, device typologies, end-user requirements, service modalities, and gantry architectures to strategic decision-making

A nuanced understanding of product and service segmentation is essential to align technology offerings with clinical use cases and institutional capabilities. In terms of clinical application, cardiology, neurology, and oncology represent distinct demand drivers; oncology remains particularly dynamic, with differentiation between FDG-based imaging that supports broad metabolic assessment and non-FDG tracers that target specific biological pathways or receptor profiles. These application-level distinctions influence scanner selection criteria, tracer logistics, and the design of imaging protocols.

Device type considerations further refine deployment decisions. Fixed systems typically serve high-volume centers where throughput and comprehensive functionality are priorities, while mobile units provide flexibility for outreach programs and shared-service arrangements among smaller institutions. End-user diversity matters as well: diagnostic centers prioritize throughput and ease of scheduling, hospitals balance inpatient and outpatient workflows and may require integrated electronic health record connectivity, and research institutes value modularity and advanced quantitative capabilities. Within hospital settings, private facilities often emphasize customer experience and value-added service agreements, whereas public hospitals focus on cost-effectiveness and broad access.

Service type choices-installation, maintenance, and upgrades-determine long-term performance and lifecycle economics. Proactive maintenance regimes and structured upgrade paths can extend useful life and preserve image quality, while installation quality affects initial calibration and regulatory compliance. Gantry architecture, whether multi-slice or single-slice, has implications for spatial resolution, scan time, and compatibility with advanced reconstruction techniques. Integrating these segmentation lenses yields a comprehensive foundation for matching product roadmaps and service models to market needs.

Regional nuances across the Americas, Europe-Middle East-Africa, and Asia-Pacific that shape procurement preferences, service models, and tracer logistics across diverse healthcare systems

Regional dynamics create varied demand characteristics and operational considerations that influence how stakeholders prioritize investment and deployment. In the Americas, healthcare systems display a wide spectrum of payer models and capital financing approaches, and large tertiary centers often act as early adopters of advanced imaging modalities. As a result, emphasis is placed on integrated workflows, robust service networks, and compatibility with a range of radiotracers to support complex oncologic, neurologic, and cardiac imaging programs.

The Europe, Middle East & Africa region encompasses diverse regulatory environments and procurement modalities, driving a need for adaptable commercial strategies. In several markets, publicly funded health systems prioritize cost-effective solutions and long-term maintenance agreements, while private centers compete on service differentiation and rapid access. Cross-border collaboration and regional distribution partnerships are common approaches to address logistical challenges and to ensure continuity of tracer supply in markets with limited cyclotron infrastructure.

Asia-Pacific presents a broad mix of rapidly expanding capacity and technology adoption alongside mature centers of excellence. High population density in large metropolitan areas creates demand for scalable solutions, including mobile deployments to extend access to peripheral regions. Additionally, local manufacturing initiatives and strategic alliances between global vendors and regional partners are influencing product localization, regulatory submission timelines, and aftermarket service models. Understanding these regional nuances is essential for aligning product offerings and service footprints with on-the-ground operational realities.

How competitive advantage is shifting toward integrated platforms that combine hardware performance, software intelligence, service excellence, and strategic tracer partnerships

Competitive dynamics are increasingly defined by the interplay between hardware innovation, software ecosystems, and service excellence. Leading suppliers pursue strategies that combine platform performance with scalable software solutions that enable quantitative imaging, workflow automation, and remote diagnostics. Partnerships with radiopharmaceutical suppliers and research institutions are becoming central to differentiated value propositions, enabling tailored tracer-support programs and clinical evidence generation that reinforce diagnostic positioning.

Service and aftermarket offerings represent a growing revenue and differentiation vector. Extended warranties, performance-based service contracts, and remote-monitoring capabilities are being positioned to reduce downtime and provide predictable lifecycle economics for providers. At the same time, modular hardware architectures and upgrade pathways help vendors preserve installed-base relationships while offering incremental feature improvements without complete system replacement.

Collaborative commercialization models-ranging from joint ventures to localized manufacturing and distribution agreements-help vendors address tariff exposures and regulatory complexities in target markets. In parallel, some companies are investing in training and accreditation programs for clinical teams to support advanced protocols and novel tracers, thereby accelerating clinical adoption. Together, these strategic moves indicate that competitive advantage increasingly hinges on integrated solutions that combine technical excellence with service depth, regulatory insight, and clinical partnership.

Practical, prioritized recommendations for manufacturers, providers, and distributors to strengthen supply resilience, expand service value, and accelerate clinical adoption of PET-CT technologies

To capture both clinical impact and commercial value, industry leaders should adopt a set of pragmatic, prioritized actions that balance near-term resilience with long-term positioning. First, diversify supply chains and evaluate opportunities for regional assembly or local partnerships to reduce exposure to trade-policy disruptions and to shorten lead times for critical spares. This pragmatic approach will strengthen service continuity and provide procurement flexibility across different payer environments.

Second, invest in software and analytics capabilities that enhance image quantitation, workflow automation, and remote service diagnostics. These capabilities not only improve diagnostic consistency but also create recurring value through service subscriptions and platform monetization. Third, expand service footprints through preventive maintenance programs, extended warranties, and outcome-oriented service contracts that align vendor incentives with clinical uptime and image quality.

Fourth, pursue tracer and research collaborations to broaden clinical applications beyond conventional agents, supporting theranostic programs and specialty imaging needs. Fifth, tailor commercial models to regional realities by offering modular financing, mobile deployment options, and training programs that build local clinical capacity. Finally, engage proactively with regulators and payers to align evidence generation plans with reimbursement expectations and quality frameworks, ensuring smoother adoption pathways and sustained clinical impact.

A transparent, mixed-methods research approach that blends primary interviews, technical reviews, regulatory analysis, and cross-validation to ensure robust, actionable insights

The research synthesis underpinning this report is grounded in a mixed-methods approach that emphasizes triangulation of primary insights, technical literature, and regulatory documentation. Primary research included structured interviews with clinical leaders, imaging physicists, service managers, and procurement specialists to elicit operational challenges, technology priorities, and decision criteria across diverse care settings. These qualitative inputs were complemented by device-level technical reviews, peer-reviewed publications, and public regulatory filings to validate performance attributes and compliance pathways.

Secondary evidence streams involved analysis of clinical trial registries, tracer development pipelines, and conference proceedings to capture emerging applications and technology directions. Where applicable, anonymized case studies and operational audits informed assessments of installation practices, maintenance regimes, and service model efficacy. Throughout the process, findings were cross-validated with subject-matter experts to ensure accuracy and to surface divergent perspectives.

Limitations were acknowledged and addressed through sensitivity checks and methodological safeguards. Data quality controls included source verification, reviewer adjudication, and a clear audit trail for inferential claims. The methodology emphasizes transparency and reproducibility, providing clients with confidence in the reliability of the insights and the contextual relevance for strategic decision-making.

Concluding synthesis that links technological advances, service models, and policy dynamics to strategic imperatives for optimizing PET-CT deployment, clinical value, and resilience

The synthesis presented throughout this executive summary underscores that PET-CT remains a critical diagnostic and research tool whose strategic value is amplified by recent technological and organizational shifts. Innovations in detector technology, reconstruction algorithms, and software-driven workflow enhancements are increasing diagnostic yield and operational efficiency, while evolving tracer landscapes and hybrid clinical paradigms expand the modality's clinical footprint. At the same time, trade-policy perturbations and regional nuances in procurement, regulation, and infrastructure create differentiated operational challenges and strategic opportunities.

For stakeholders, the imperative is to think holistically: align product design with service offerings, build supply chains that reduce exposure to external shocks, and invest in software and clinical partnerships that generate sustained value. By doing so, manufacturers, providers, and distributors can ensure that PET-CT capabilities deliver both improved patient outcomes and predictable operational performance. The insights and recommendations in this report are intended to inform capital allocation, product roadmaps, and collaborative strategies that will shape the next phase of PET-CT adoption and clinical integration.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. PET-CT Scanners Market, by Device Type

  • 8.1. Fixed
  • 8.2. Mobile

9. PET-CT Scanners Market, by Service Type

  • 9.1. Installation
  • 9.2. Maintenance
  • 9.3. Upgrades

10. PET-CT Scanners Market, by Gantry Type

  • 10.1. Multi-Slice
  • 10.2. Single-Slice

11. PET-CT Scanners Market, by Application

  • 11.1. Cardiology
  • 11.2. Neurology
  • 11.3. Oncology
    • 11.3.1. FDG Tracer
    • 11.3.2. Non-FDG Tracer

12. PET-CT Scanners Market, by End User

  • 12.1. Diagnostic Centers
  • 12.2. Hospitals
    • 12.2.1. Private Hospitals
    • 12.2.2. Public Hospitals
  • 12.3. Research Institutes

13. PET-CT Scanners Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. PET-CT Scanners Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. PET-CT Scanners Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States PET-CT Scanners Market

17. China PET-CT Scanners Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Analogic Corporation
  • 18.6. Canon Medical Systems Corporation
  • 18.7. Fujifilm Holdings Corporation
  • 18.8. General Electric Company
  • 18.9. Hitachi, Ltd.
  • 18.10. Koninklijke Philips N.V.
  • 18.11. MR Solutions Ltd.
  • 18.12. Neusoft Medical Systems Co., Ltd.
  • 18.13. PerkinElmer, Inc.
  • 18.14. Positron Corporation
  • 18.15. Segami Corporation
  • 18.16. Shimadzu Corporation
  • 18.17. Siemens Healthineers AG
  • 18.18. United Imaging Healthcare Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL PET-CT SCANNERS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PET-CT SCANNERS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PET-CT SCANNERS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PET-CT SCANNERS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PET-CT SCANNERS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PET-CT SCANNERS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES PET-CT SCANNERS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA PET-CT SCANNERS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PET-CT SCANNERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PET-CT SCANNERS MARKET SIZE, BY FIXED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PET-CT SCANNERS MARKET SIZE, BY FIXED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PET-CT SCANNERS MARKET SIZE, BY FIXED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PET-CT SCANNERS MARKET SIZE, BY MOBILE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PET-CT SCANNERS MARKET SIZE, BY MOBILE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PET-CT SCANNERS MARKET SIZE, BY MOBILE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PET-CT SCANNERS MARKET SIZE, BY INSTALLATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PET-CT SCANNERS MARKET SIZE, BY INSTALLATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PET-CT SCANNERS MARKET SIZE, BY INSTALLATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PET-CT SCANNERS MARKET SIZE, BY MAINTENANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PET-CT SCANNERS MARKET SIZE, BY MAINTENANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PET-CT SCANNERS MARKET SIZE, BY MAINTENANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PET-CT SCANNERS MARKET SIZE, BY UPGRADES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PET-CT SCANNERS MARKET SIZE, BY UPGRADES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PET-CT SCANNERS MARKET SIZE, BY UPGRADES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PET-CT SCANNERS MARKET SIZE, BY MULTI-SLICE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PET-CT SCANNERS MARKET SIZE, BY MULTI-SLICE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PET-CT SCANNERS MARKET SIZE, BY MULTI-SLICE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PET-CT SCANNERS MARKET SIZE, BY SINGLE-SLICE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PET-CT SCANNERS MARKET SIZE, BY SINGLE-SLICE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PET-CT SCANNERS MARKET SIZE, BY SINGLE-SLICE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PET-CT SCANNERS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PET-CT SCANNERS MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PET-CT SCANNERS MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PET-CT SCANNERS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PET-CT SCANNERS MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PET-CT SCANNERS MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PET-CT SCANNERS MARKET SIZE, BY FDG TRACER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PET-CT SCANNERS MARKET SIZE, BY FDG TRACER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PET-CT SCANNERS MARKET SIZE, BY FDG TRACER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PET-CT SCANNERS MARKET SIZE, BY NON-FDG TRACER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PET-CT SCANNERS MARKET SIZE, BY NON-FDG TRACER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PET-CT SCANNERS MARKET SIZE, BY NON-FDG TRACER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PET-CT SCANNERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PET-CT SCANNERS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PET-CT SCANNERS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PET-CT SCANNERS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PET-CT SCANNERS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PET-CT SCANNERS MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PET-CT SCANNERS MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PET-CT SCANNERS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PET-CT SCANNERS MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PET-CT SCANNERS MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PET-CT SCANNERS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PET-CT SCANNERS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PET-CT SCANNERS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PET-CT SCANNERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. AMERICAS PET-CT SCANNERS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 62. AMERICAS PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS PET-CT SCANNERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 69. NORTH AMERICA PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA PET-CT SCANNERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. LATIN AMERICA PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. LATIN AMERICA PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA PET-CT SCANNERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA PET-CT SCANNERS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA PET-CT SCANNERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE PET-CT SCANNERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. MIDDLE EAST PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. MIDDLE EAST PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. MIDDLE EAST PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST PET-CT SCANNERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. MIDDLE EAST PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. AFRICA PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. AFRICA PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. AFRICA PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. AFRICA PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 115. AFRICA PET-CT SCANNERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. AFRICA PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC PET-CT SCANNERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL PET-CT SCANNERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. ASEAN PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. ASEAN PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. ASEAN PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. ASEAN PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. ASEAN PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN PET-CT SCANNERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. ASEAN PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 134. GCC PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. GCC PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. GCC PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. GCC PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. GCC PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. GCC PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 140. GCC PET-CT SCANNERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 141. GCC PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPEAN UNION PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPEAN UNION PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPEAN UNION PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPEAN UNION PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPEAN UNION PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPEAN UNION PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPEAN UNION PET-CT SCANNERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPEAN UNION PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 150. BRICS PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. BRICS PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. BRICS PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. BRICS PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. BRICS PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 155. BRICS PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 156. BRICS PET-CT SCANNERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. BRICS PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 158. G7 PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. G7 PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. G7 PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. G7 PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. G7 PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 163. G7 PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 164. G7 PET-CT SCANNERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 165. G7 PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 166. NATO PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 167. NATO PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. NATO PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. NATO PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. NATO PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 171. NATO PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 172. NATO PET-CT SCANNERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 173. NATO PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. UNITED STATES PET-CT SCANNERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 176. UNITED STATES PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. UNITED STATES PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. UNITED STATES PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. UNITED STATES PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 180. UNITED STATES PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 181. UNITED STATES PET-CT SCANNERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. UNITED STATES PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 183. CHINA PET-CT SCANNERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 184. CHINA PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. CHINA PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. CHINA PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. CHINA PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 188. CHINA PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 189. CHINA PET-CT SCANNERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 190. CHINA PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)